Follicular lymphoma is a diverse disease, both biologically and clinically. Patients may present with indolent, asymptomatic disease or more aggressive, symptomatic disease with high tumor burden.

Looking for reliable medications to treat 'Follicular Lymphoma'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name medications.

—Most follicular lymphoma cases exhibit classic clinicopathologic and molecular features, but a range of less common histopathologic variants have been documented, confounding diagnosis and ...

Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.

For evaluating response to treatment for follicular lymphoma, computed tomography (CT) has been considered the gold standard, and most clinical studies and trials have used CT as a tool for ...

I no longer had slow-growing, non-Hodgkin’s follicular lymphoma. I now was sick with DLBCL – or diffuse large B-cell lymphoma. That explained the rapid growth, the pain, the kidney impact ...

Bristol Myers Squibb announced that the European Commission (EC) has granted approval to Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, ...